Over the course of the projected period, rising research and development initiatives involving research antibodies are anticipated to drive market expansion. Market participants are working on product approvals, which is anticipated to accelerate the expansion of the global market for research antibodies over the forecast period. For instance, Tepezza (TM) (teprotumumab-trbw), a therapeutic monoclonal antibody for the treatment of thyroid eye disease (TED), was approved by the U.S. FDA (Food and Drug Administration) on January 21, 2020. Horizon Therapeutics plc is a biopharmaceutical company with a focus on drug research, development, and commercialization. Uncommon autoimmune disease TED is characterised by proptosis (eye bulging), diplopia (double vision), impaired vision, pain, inflammation, and facial deformities. It is also a serious, progressive, and eyesight-threatening disorder. Only Tepezza has been given FDA (Food and Drug Administration) approval as a TED treatment. Over the projected period, an increase in market participants' partnerships is anticipated to fuel market expansion for research antibodies.
According to Coherent Market Insights, According to projections, the global market for Research Antibodies will increase at a CAGR of 5.9% from 2022 to 2030, reaching US$ 3,574.6 Mn in 2022.
Leading Companies in the Research Antibodies Industry:
1. Thermo Fisher Scientific
The company was started in 1956 and is located in Waltham, Massachusetts, U.S. The business offers applications, reagents and consumables, and scientific apparatus. Thermo Fisher Scientific stated in January 2021 that it had purchased Groupe Novasep SAS's viral vector maker, Henogen SA, in Belgium. In an all-cash agreement worth US$2.6 billion, the business agreed to acquire Nordic Capital's British diagnostics company, The Binding Site Group, in October 2022.
2. Novartis
The company was founded in March 1996 and has its main offices in Basel, Switzerland, and Cambridge, Massachusetts, in the United States. Novartis provides coverage for all types of medications, including authorization, over-the-counter, immunisations, diagnostics, eyewear, and veterinary care. Through its firms, Novartis engages in a number of direct activities, including managing, advertising, operations, and research.
3. Takeda Pharmaceutical Company
Takeda, a pharmaceutical company, was founded in 1781, and on January 29, 1925, it was incorporated. Oncology, uncommon disorders, neurology, gastroenterology, particle medicine, and immunisations are some of the areas of research that the company is most interested in. In February 2023, Nimbus Therapeutics' TYK2 Programme Subsidiary was fully acquired by Takeda. A collaboration and licencing agreement was signed in October 2022 by Takeda, Zedira, and Dr. Falk Pharma to collaborate on developing a first-in-class treatment for celiac disease.
4. Bio-rad Laboratories
The firm was founded in 1952 and is based in California, United States. The business produces and sells analytical instruments, clinical diagnostics, and equipment for use in life science research. Products and systems from Bio-Rad Laboratories are used to separate complicated chemical and biological materials as well as to recognise, examine, and purify their constituent parts. A cooperation between Bio-Rad and Roche was declared in March 2021.
5. F.Hoffmann La Roche Ltd.
The company was started in 1896 and has its headquarters in Basel, Switzerland. The business offers medications for cancer and organ transplants as well as in-vitro diagnostics. Oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious illnesses, and microbiology are among the specialties of the company. Roche announced in March 2021 that it would buy GenMark Diagnostics for $1.8 billion.
6. Agilent Technologies
The company was established in 1999 and is located in California, United States. Agilent Technologies, Inc. offers fundamental electronic measurement and bio-analytical solutions to the chemical analysis, communications, electronics, and life sciences industries. The business provides semiconductor and board testing, as well as electronic and bioanalytical measurement.
7. Danaher Corporation
The company was founded in 1969 and has its main office in Washington, D.C., U.S. In the fields of test and measurement, environmental technology, life sciences, dentistry, and industrial technologies, Danaher Corporation develops, produces, and sells professional, medical, industrial, and commercial goods and services. Danaher acquired General Electric Life Sciences' biopharma division in March 2020 for $21.4 billion, and the company was given the new name Cytiva.
Definition: In laboratory procedures used for research, like western blotting and other techniques, research antibodies play a crucial role as instruments.Detection methods employed by scientists are crucial for research antibodies.
